RocheHeadquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80'000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information:

Roche RSS Channel

Title Filter      Display #  
# Article Title
1 Roche with good start in 2014
2 Roche delivers strong 2013 results
3 Roche and Polyphor join efforts to combat multi-drug-resistant bacterial infections
4 Roche posts strong sales growth in the first nine months of 2013
5 Roche inaugurates Translational and Clinical Research Center at the Alexandria Center for Life Science in New York City
6 Christoph Franz nominated to become new Roche Chairman
7 Roche halts investigation of aleglitazar
8 Roche Group posts strong sales growth in the first quarter
9 Roche launches new process for accessing clinical trial data
10 FDA approves Roche's Kadcyla (trastuzumab emtansine), the first antibody-drug conjugate for treating HER2-positive metastatic breast cancer
11 Roche delivers strong 2012 results
12 Roche reports positive studies of MabThera given by subcutaneous injection
13 Roche and the Innovative Medicines Initiative join forces to promote use of Nobel Prize-winning stem cell technology
14 Results from the positive phase III AVAglio study
15 Roche Group posts strong sales growth in the third quarter
16 Roche leads healthcare sector in key sustainability index for fourth consecutive year
17 Roche committed to innovation and growth
18 Roche and Lucerne Festival renew partnership and launch new project for young composers
19 FDA approves Lucentis (ranibizumab injection) for treatment of diabetic macular edema
20 The Phase III AVAglio study met its co-primary endpoint
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]